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Abstract:
This paper explores the structure of the major code of ethics regarding human
experimentation, the Nuremberg Code. The paper begins with an explanation of the modern
ethical standards and how they were established. Following this background is an inquiry into
the actual force the Nuremberg Code carries in American courts, and how cultural values are
reﬂected in the courts’ decisions. These ethical codes are then explored through the lens of
the AIDS vaccine research being conducted currently in Africa and other third-world
countries. This more philosophical part of the paper questions the strength of the Nuremberg
Code, and highlights some of its weaknesses with regards to real-life crises. In conclusion, the
paper exposes the many conﬂicting aspects of this ethical debate between human autonomy
and medical emergency and reveals that while perhaps there is no “right” answer at this time,
the debate itself is a valuable check on our ambitions.
1I. Introduction
The progression of modern science has given the world the ability to control and conquer deadly diseases,
and to understand how the human body functions. Babies born today in wealthy countries like the United
States of America enjoy average life expectancies of 76.7 years1. The eradication of smallpox and polio are
only two of the myriad triumphs that science has had over the cruelties of nature, and many in the scientiﬁc
community continue to search for new and innovative ways to cure disease. Congress spends billions of dollars
a year funding medical research in hopes that breakthroughs can be made that will save lives and further
improve the quality of life and healthcare for Americans and citizens of the world. However, the money
dispersed by Congress is not divided according to how many victims of each disease there are, but rather
is a game of politics, with those groups possessing lobbying power and visibility receiving disproportionate
amounts of funds.2 This method of division reﬂects not only the power of lobbying, but also the diﬀerent
levels of urgency that surround diﬀerent diseases. Whereas many methods currently exist for controlling
and treating ailments like heart disease, viruses such as AIDS remain elusive killers, with no methods of
prevention known, apart from education and behavioral practices.
The AIDS pandemic is under a certain level of control in the United States and in Europe, but recent years
have shown that it has reached staggering, plague-like levels in sub-Saharan Africa, with cases in Asia on the
rise as well. In sub-Saharan Africa it is estimated that nearly 30 million people are living with HIV/AIDS. In
2002 there were 3.5 million new infections and 2.4 million deaths. In India approximately 3.9 million people
were living with HIV at the end of 2001, and current research shows this number is increasing rapidly.3 AIDS
1G. Scott Thomas. “Life expectancy study: Lucky white females.” Washington Business Journal. January 18, 2002.
2For every $10 spent per cancer death on cancer research, $110 is spent per AIDS death on AIDS research and $3 is spent
per heart disease death on heart disease research. See CRS Report 97-917: Disease Funding and NIH Priority Setting
3All statistics from AIDS Epidemic Update. UNAIDS, December 2002.
2is a modern-day plague. The U.S. is under increasing pressure to lead the world in contributing money and
research to ﬁght the spread of this disease, and there are political, economic, social, and humanitarian reasons
why it should do so. The hunt for a vaccine has been in progress for nearly two decades, ever since the disease
appeared on the scene, at ﬁrst primarily in gay men and intravenous drug users. The course of this research
reﬂects not only the practices and idiosyncrasies of the scientiﬁc method generally, but also raises diﬃcult
questions of ethics and morality.
Research has been conducted on human beings for most of recorded history, as Romans performed vivisection
on slaves and gladiators and Hippocrates declared that true physicians must not do harm to their patients.4
In the modern era, however, human rights groups such as Amnesty International pay careful consideration
to experiments being done on human beings, even in the most hidden and secretive circumstances.5 Most
scholars on the subject of ethics relating to experimentation on human beings explain our modern standards
as the result of an increasing awareness of worldwide practices, and the lingering inﬂuence of one of the most
tragic episodes in the history of scientiﬁc research—the Nazi experiments during World War II. Today’s
standards set clear guidelines for human experimentation, with primary emphasis on the importance of
informed consent. These strict rules, however, can be an impediment to important studies that may lead
scientists to breakthroughs in the ﬁeld of AIDS research. A closer examination of the history of these
standards, and their actual use and importance, will reveal that much of the research being performed
today crosses ethical lines into gray areas that must be explored. The United States, which presided over
the Nuremberg trials themselves, must decide whether it is willing to compromise its purported values and
ethics in the name of scientiﬁc progress. Does the end goal of a potential AIDS vaccine justify the breach
of clearly mandated ethical standards? In the current race to ﬁnd a cure, ethics may become just another
4“Primum non nocere.” (First do no harm) from Hippocratic Oath, 5th century B.C.E.
5Amnesty International Health Professionals Network groups campaign on behalf of prisoners who have been subjected to
violations of human rights that have a health-related perspective, such as deprivation of medical care and breaches of medical
ethics. See www.amnesty.org
3casualty.
II. Modern Standards Regarding Human Experimentation
The standards that exist today can only be clearly understood through the lens of history, by examining
the events that inspired their adoption. There is a long history of human experimentation. An early
example comes from 1796, when Edward Jenner injected a healthy eight-year-old with cowpox, and then
smallpox, helping to discover the vaccine.6 In 1906 Dr. Richard Strong, a professor of tropical medicine at
Harvard, experimented with cholera and killed 13 prisoners.7 But it was the horrors of the Nazi concentration
experiments during World War II that propelled the world to consider the adoption of international standards
of ethics for human research. The experiments performed by Nazi doctors demonstrated a reckless disregard
for the value of all life considered “other” by the Aryan establishment.
The experiments themselves are so horriﬁc as to be nearly unimaginable. Hitler enlisted doctors to help
justify his racial policies with “scientiﬁc” proof, and also to run his death camps and experimental labs.8
In one experiment performed at Dachau, inmates were placed in chambers that simulated altitudes as high
as 68,000 feet, in order to see how German soldiers would react if they had to eject from their aircraft at
high altitudes. Sigmund Rascher, who performed these experiments, was said to have dissected the victims’
brains while they were still alive in order to show that tiny air bubbles in the brain caused the damage.
Of the 200 people who were used in this experiment, 80 died immediately and 120 others were executed
6See “A Chronology of Human Research” by Vera Hassner Sharav. See www.researchprotection.org/history/chronology.html
7Id.
8Annas, George J., Grodin, Michael A. “Medical Ethics and Human Rights: Legacies of Nuremberg” Hofstra Law and Policy
Symposium 1999 p.112
4thereafter.9
In another infamous study, Dr. Josef Mengele studied pairs of twins in order to ﬁnd a way to quickly increase
the Aryan population. After collecting data from the twins, Mengele murdered them with chloroform shots
to the heart, although amazingly 20% of the pairs managed to survive.10 Clearly, people all over the
world were shocked and horriﬁed upon hearing of these atrocities. And though this spurred the Doctors’
Trials at Nuremberg, and the adoption of the Nuremberg Code, American researchers continued to perform
fundamentally unethical experiments with human subjects.
One of the darkest chapters in American scientiﬁc research history was the Tuskegee syphilis study. The
study began in 1932, and for 40 years poor African-American men with syphilis were followed while doctors
studied the natural course of the disease. The men were not informed of their condition, or the purpose of
the study. Penicillin, a known cure, was never administered to these men.11 In fact, the experiment was
so horrendously unethical that President Clinton felt it was necessary to make an oﬃcial apology to the
survivors and the families of the victims. In his oﬃcial statement he said: “The United States government
did something that was wrong – deeply, profoundly, morally wrong. It was an outrage to our commitment
to integrity and equality for all our citizens. To the survivors, to the wives and family members, the children
and the grandchildren, I say what you know: No power on Earth can give you back the lives lost, the pain
suﬀered, the years of internal torment and anguish. What was done cannot be undone. But we can end the
silence. We can stop turning our heads away. We can look at you in the eye and ﬁnally say on behalf of the
American people, what the United States government did was shameful, and I am sorry.”12
The Nazi experiments and the Tuskegee study are only two examples of ethical violations that have occurred
in the ﬁeld of scientiﬁc research on humans. There are countless other examples, both known and unknown.
9http://www.pbs.org/wgbh/nova/holocaust/experiside.html
10Id.
11Jones, James H. Bad Blood: The Tuskegee Syphilis Experiment. New York : Maxwell McMillan International, c1993.
12The White House, Oﬃce of the Press Secretary. “Apology for Study Done in Tuskegee.” May 16, 1997
5But it was the high visibility and extremity of the Nazi doctors that helped to create an international
discussion on ethical standards.
There are two codes that shape most modern approaches to human experimentation. The earlier document
is the Nuremberg Code, created in 1947 following the Doctors’ Trials at Nuremberg. The trial, which began
in December of 1946, was under the order of the American Military Tribunal. Twenty-three German doctors
were tried for crimes against humanity. Seven were eventually executed. In his opening statement, the
prosecutor explained that “in some instances the true object of these experiments was not how to rescue
or to cure, but how to destroy and kill. The sterilization experiments were clearly purely destructive in
purpose. The prisoners at Buchenwald who were shot with poisoned bullets were not guinea pigs to test an
antidote for the poison; their murderers really wanted to know how quickly the poison would kill.”13 The
evidence introduced in this trial was obviously shocking and disturbing. The result of this outrage was the
Nuremberg Code.
The Code emerged because two of the American doctors who had worked with the prosecution were worried
because some of the defendants had argues that there existed no international code on the ethics of human
experimentation. Dr. Alexander therefore submitted to the United States Counsel for War Crimes a memo-
randum containing six basic factors that deﬁned legitimate human research. In the verdict of the trial these
six points were expanded to ten, and these factors became known as the Nuremberg Code.14 The main tenet
of the Code is the value of informed consent, as embodied in principle one: “The voluntary consent of the
human subject is absolutely essential.” The judges went on to explain in detail what such consent entailed,
and stressed that in weighing the competing interests of the individual’s autonomy and freedom and the
13From the opening statement by Teleford Taylor [from Trials of War Criminals before the Nuremberg Military Tribunals
under Control Council Law No. 10. Nuremberg, October 1946–April 1949. Washington, D.C.: U.S. G.P.O, 1949–1953.
14See The United States Holocaust Memorial Museum online, http://www.ushmm.org/research/doctors/code expl.htm
6advancement of science, the rights of the individual should always triumph.15 The other nine principles are
as follows:
2. The experiment should be such so as to yield fruitful results for the good of society, unprocurable
by other methods or means of study, and not random and unnecessary in nature.
3. The experiment should be so designed and based on the results of animal ex-
perimentation and a knowledge of the natural history of the disease or other problem under
study that the anticipated results will justify the performance of the experiment.
4. The experiment should be so conducted as to avoid all unnecessary physical and mental
suﬀering and injury.
5. No experiment should be conducted where there is an a priori reason to believe that death
or disabling injury will occur; except, perhaps, in those experiments where the experimental
physicians also serve as subjects.
6. The degree of risk to be taken should never exceed that determined by the humanitarian
importance of the problem to be solved by the experiment.
7. Proper preparations should be made and adequate facilities provided to protect the exper-
imental subject against even remote possibilities of injury, disability, or death.
8. The experiment should be conducted only by scientiﬁcally qualiﬁed persons. The highest
degree of skill and care should be required through all stages of the experiment of those who
conduct or engage in the experiment.
9. During the course of the experiment the human subject should be at liberty to bring the
experiment to an end if he has reached the physical or mental state where continuation of the
experiment seems to him to be impossible.
10. During the course of the experiment the scientist in charge must be prepared to terminate
the experiment at any stage, if he has probable cause to believe, in the exercise of the good
faith, superior skill and careful judgment required of him that a continuation of the experiment
is likely to result in injury, disability, or death to the experimental subject.16
In the years following the Nuremberg Trials, many physicians felt as though the Code was deﬁcient and
inapplicable to basic research, having meaning only in the context of war crimes.17 In response to this
dissatisfaction, the World Medical Assembly adopted the Declaration of Helsinki in 1964. This document
consists of recommendations to physicians by physicians, making it more relevant to the realities of research.18
But the basic ideas of the Nuremberg Code are still held up as an example of basic standards of ethical
15Katz, Jay. “Human Sacriﬁce and Human Experimentation: Reﬂections at Nuremberg.” Yale Journal of International Law.
Summer 1997. p.413
17Roman, Joanne. “U.S. Medical Research in the Developing World: Ignoring Nuremberg.” Cornell Journal of Law and
Public Policy. Spring 2000 p.451.
18Id. at 452
7research. The Code, however, has not been formally adopted as law. By examining the role the Code has
played in American courts it becomes clear that, while the intentions of the judges who promulgated this
Code were salutary, the courts in the United States since World War II have not used the Code directly as
a measure of ethical behavior.
In one of the earliest American court cases discussing the role of consent in experimentation, the Supreme
Court of Michigan stated that “if the general practice of medicine and surgery is to progress, there must
be a certain amount of experimentation carried on; but such experiments must be done with the knowledge
and consent of the patient or those responsible for him, and must not vary too radically from the accepted
method of procedure.”19 This attitude of encouragement for medical innovation has played an important
role in shaping the way courts have handled these diﬃcult ethical questions. Americans have always prided
themselves as being on the cutting edge of scientiﬁc progress, forging the road into a future of cures and
vaccines. Another pre-World War II case illustrates this appreciation for new techniques in the medical arena.
In 1941 in New York, a physician had his license taken away after being accused of fraud and deceit when
he treated a cancer patient with an experimental formula after informing the patient that it may or may not
work, but would not be harmful. The patient consented to this line of treatment.20 The court overturned
the suspension and noted that “it is not fraud or deceit for one already skilled in the medical art, with the
consent of the patient, to attempt new methods when all other known methods of treatment had proved
futile and least of all when the patient’s very life has been despaired of. Initiative and originality should not
be thus eﬀectively stiﬂed, especially when undertaken with the patient’s full knowledge and consent, and as
a last resort.”21 This court reﬂected the American values of innovation and progress, and declared that as
long as there was consent, such methods were ethically acceptable. Other pre-War cases espoused the same
19Fortner v. Koch, 272 Mich. 273, 282 (1935)
20Stammer v. Board of Regents, 262 A.D. 372 (N.Y. App. Div. 1941)
21Id. at 373-374
8standards.22
As World War II drew to a close, America and the world began to learn about the hidden horrors of the Nazi
regime. Stories of experiments and torture were revealed, some too horrible to even believe. As previously
discussed, these experiments were tantamount to physical and psychological torture, performed under the
auspices of “medical” research. In fact, the Jewish, Gypsy, and countless other “undesirable” victims were
simply discarded as valueless under Nazi rule. The Nuremberg trials put these medical doctors and Nazi
oﬃcials on trial for crimes against humanity, and the entire free world declared their intent to create a world in
which this kind of tragedy could never occur again. In America, however, the newly created Nuremberg Code
was not discussed in the courts until decades after the close of the trials. This is quite curious, considering
that all the judges at the Doctors’ Trial were American, as well as the prosecutors.23 Before 1973, the only
time the Nazi doctors were even alluded to was by a dissenting judge in a case that allowed the transplant
of a kidney from an institutionalized individual for his brother. Judge Steinfeld stated that “because of [his]
indelible recollection of a government which, to the everlasting shame of its citizens, embarked on a program
of genocide and experimentation with human bodies [he] ha[s] been more troubled in reaching a decision in
this case than in any other. [His] sympathies and emotions are torn between a compassion to aid an ailing
young man and a duty to fully protect unfortunate members of society.”24
Utilitarianism seemed to be the American value most relied on at this time, as the Cold War loomed and the
excitement over the polio vaccine justiﬁed its being tested on institutionalized mentally retarded children.25
22See Bonner v. Moran, 126 F.2d 121, 121 (D.C. Cir. 1941) (ordering a retrial and stating that a ﬁnding of parental consent
would justify a surgery on a 15 year old boy)
23Annas, George J. “Mengele’s Birthmark: The Nuremberg Code in United States Courts.” Journal of Contemporary Health
Law and Policy. Spring 1991 p.24
24Strunk v. Strunk, 445 SW2d 145, 149 (Ky. Ct. App. 1969)
25Annas at 24
9One of the next cases to refer to the Nuremberg Code was not until 1980, in a New Jersey Supreme Court
case involving a physician who was ﬁred when she refused to continue developing and testing a drug because
she believed one of the ingredients to be harmful and argued that the Hippocratic oath prohibited her from
continuing the research.26 The New Jersey Supreme Court declared that “Dr. Pierce espouses a doctrine
that would lead to disorder in drug research. Under her theory, a professional employee could redetermine
the propriety of a research project even if the research did not involve a violation of a clear mandate of public
policy. Chaos would result if a single doctor engaged in research were allowed to determine, according to his
or her individual conscience, whether a project should continue.”27 In dissent, Judge Pashman explained the
societal value of ethical codes, and cited the Nuremberg Code as one of four examples of ethical constraints
put on those in the medical profession.28 The majority concluded that the ingredient was merely controversial
and not declared unsafe, and hence the physician was not entitled to further employment simply because
her sense of ethics was oﬀended.29 This court seems completely insensitive to fact that it was not simply
her personal ethics that were challenged, but also her ethics as a physician. It seems only the sole dissenting
judge recognized the importance of this distinction. As shown from this exploration, the American courts
did not openly embrace the spirit and meaning of the Nuremberg Code, instead putting a high value on the
beneﬁts of innovation and experimentation. In fact, even a case which did cite the Nuremberg Code as the
standard of ethics of nontherapuetic research found a doctor not liable for failing to warn of risks the could
not be declared “reasonably foreseeable”.30
The Supreme Court did not directly discuss the Nuremberg Code until 1987, in the context of the United
States military.31 In the Stanley case, the plaintiﬀ, James Stanley, was given LSD without his knowledge




30See Whitlock v. Duke University, 637 F. Supp. 1463 (M. D. N. C. 1986)
31United States et. al. v. Stanley, 483 U. S. 669 (1987)
10or consent, in order for the Army to test how soldiers performed under the inﬂuence of this hallucinogenic
drug. Stanley’s mental health was permanently damaged, resulting in his divorce. In fact, he was not even
informed that he had been given LSD until 1975.32 In Justice Scalia’s opinion, he stated that an active
serviceman could not sue the government for injuries sustained as a result of experimentation, even though
this particular experiment clearly violated the Nuremberg Code’s requirement of informed consent. Such a
ﬁnding indicates that the Code was simply a guideline with no teeth. In his partial dissent, Justice Brennan
explicitly emphasizes the importance of the Nuremberg Code and the historical era out of which that Code
arose.33 This is a diﬃcult case to use as a measure of the role of the Nuremberg Code in the Supreme Court,
however, because it is easy to distinguish the case based on its military context. The only other Supreme
Court case to mention Nuremberg does so only in a footnote about informed consent.34 This, however, was
in the contexts of prisons, yet again a very particularized situation. In whole, the Supreme Court has given
little indication as to the role of the Nuremberg Code in American cases. Perhaps America imagines itself as
so distant from Nazi Germany that it does not clearly see the relation it should have to the Nuremberg Code.
Overall, the case law in American courts shows an emphasis on innovation in science and technology, not a
strong insistence on human rights. This general sensibility translates to the world outside of the courtroom
as well, as modern crises put pressure on the scientiﬁc community.
III. Ethics in Practice
The modern day AIDS epidemic provides a clear illustration of the dilemmas that arise when scientiﬁc
32Annas at 38
33Stanley at 687
34Washington et al. v. Harper, 494 U.S. 210, 237 (1990)
11research is constrained by ethical codes, and how American researches have responded to, and eluded, such
constraints. The areas of the world most devastated by this disease are the least developed countries,
particularly sub-Saharan Africa.35 Since 1997 the Center for Disease Control (CDC) has been sponsoring
research trials in Africa and other regions of the world in which researchers study the transmission of HIV
from pregnant women to their babies. This study is an attempt to ﬁnd a cheaper way to prevent this
transmission, though a more expensive long-term AZT treatment already exists.36 Despite the fact that this
treatment already exists, the research done by the CDC uses a placebo group to compare results, a decision
which will lead to the infection of more than 1,000 babies.37
The implications of using a placebo group when a known treatment exists are quite complex and raise
many moral issues. Many critics believe that using a placebo when a known treatment exists is inherently
unethical, especially when the disease in question is a fatal one.38 Beyond the use of a placebo, some trials in
developing countries are conducted in a manner such that the participants are not as informed of the details
of the study and of their own health as they would be in America. For example, in one Ugandan community,
an experiment was conducted to test the eﬀects of increased viral loads on heterosexual transmission of
HIV. A total of 415 couples were enrolled, one partner in each pair being HIV positive. The researchers
visited the pairs four times over the course of 30 months and collected data and specimens. Ninety people
became infected with the virus over this time period, during which the researchers never informed them that
their partner was HIV positive, and did not oﬀer anti-retroviral drug therapies.39 The results showed that
increased viral load did increase the likelihood of transmission of HIV through heterosexual sex and that
anti-retroviral drugs could help reduce this spread. However, such drug therapies are too expensive to be
35Pitler, Lisa. “Ethics of AIDS Clinical Trial in Developing Countries: A Review.” Food and Drug Law Journal, 2002. p.134
36Dyckman, Jay. “The Myth of Informed Consent: An Analysis of the Doctrine of Informed Consent and its (Mis)application




12available in countries like Uganda. This pricing dilemma is why trials are conducted that attempt to ﬁnd
cheaper alternative methods, thus leading to the use of placebo groups.
Beyond the obstacle of cost, many other barriers exist to providing aﬀordable treatments in these under-
developed countries. Issues of lack of education, access to both pre- and post-natal care, illiteracy, male sexual
dominance, lack of alternatives to breastfeeding, and home delivery births all contribute to the diﬃculty of
providing known treatments for AIDS patients in Africa.40 Acknowledging that a crisis exists, and that if it
is not stopped, millions of people will die, researchers are placed in an ethical dilemma: do they do whatever
experiments will lead them to a cure or vaccine most rapidly, thus saving lives?; or do they adhere strictly
to all ethical standards practiced in developed countries, thus stunting the progress of their work and losing
countless patients to the disease?
One of the largest criticisms of these trials is that “the researchers and their sponsoring governments adopted
an ethical ‘double standard’: the use of the placebo in such a clinical trial would never have been allowed in
a developed country because of ethical principles.”41 All trials conducted in America are subject to the law
of Title 45 of the Code of Federal Regulations, Part 46, which is promulgated by the Department of Health
and Human Services. This statute applies to all experiments using human subjects conducted within the
United States. In addition, section 46.101(h) notes that if the research is being done in a foreign country,
that country’s procedural requirements may be substituted if they are equivalent to those provided by the
statute. This last point of the rule is often ignored by researchers in foreign countries, as they attempt to
escape the more rigid regulations required by American laws. For instance, in the United States, oﬀering
a trial where the known AZT treatment was not oﬀered and instead a placebo was used would be diﬃcult
to justify and would not pass ethical review because the AZT treatment is readily available.42 By going
40Pitler at 147
41Fidler, David P. “’Geographic Mortality’ Revisited: International Relations, International Law, and the Controversy Over
Placebo-Controlled HIV Clinical Trials in Developing Countries.” Harvard International Law Journal, Summer 2001 p. 303
42Pitler at 141
13to third-world countries, however, researchers are able to escape these requirements because the alternative
treatment in those locations is, quite sadly, nothing. Therefore, providing at least some of the research
subjects with treatment is better than what they would otherwise receive.
The researchers’ goals are noble, as they search for a way to alleviate this crisis while being constrained
by the reality of the depressed economies of these African nations. For instance, in Malawi, the cost of
the anti-retroviral treatment for an HIV-infected woman and her child (which is aﬀordable in the United
States) is greater than 600 times the yearly per capita expenditure for healthcare.43 Faced with such dismal
statistics, it is no wonder these physicians and scientists want to ﬁnd a vaccine as soon as possible. The
question that must be faced, however, is at what cost does this cure come? History has taught that people
can be blinded by external forces such as war, or threat to national security, or fear of death. The Nazi
doctors illustrated the lowest depths to which humanity can sink in its treatment of fellow human beings.
But ethical violations do not have to be as extreme as they were in World War II to be rendered egregious
or unacceptable. Many aspects of the work the researchers in Africa are performing cross boundaries into
ethical gray areas, and a further exploration of the main areas of concern will help illuminate the dilemmas
these researchers face.
The ﬁrst diﬃcult issue arises straight out of the Nuremberg Code itself, which stresses above all else the value
of informed consent. Does such truly informed consent exist in the context of the AIDS trials in Africa and
other third-world countries, or is it merely a ﬁction? Many critics believe it is impossible that the consent
these research subjects give is as informed as the Code intended “informed” to mean. The judges who created
the Nuremberg Code placed heavy emphasis on the concept of informed consent. They did not merely state
that such consent is necessary, but went on to deﬁne it in terms of the research subjects’ capacity and the
type of information that must be provided.44 The judges stated that a research subject should be informed
43Pitler at 142
44Katz at 413
14of all possible risks and hazards to be expected, the nature and duration of the experiment, and should have
suﬃcient comprehension of the topic to ensure that his or decision to truly informed. In addition, it is the
researcher who is responsible for ascertaining the quality of the consent given.45 These standards, rigorous
on their own, become even more diﬃcult to fulﬁll when viewed in light of the reality of the educational level
of many of the subjects, and the feasibility of relating often complex scientiﬁc information.
One of the obstacles in obtaining informed consent in the context of these AIDS trials is the manner in which
the subjects view the researchers. One advisory Committee found that patients-subjects “believed that ‘an
[experimental] intervention would not even be oﬀered if it did not carry some promise of beneﬁt [for them],’
and that therefore the consent process was ‘a formality’ to which they need not give much thought.”46 In this
type of setting, where the patient-subject equates research with therapy, it is diﬃcult to believe that these
subjects understand that the consent they are giving allows for the possibility that they may be receiving no
help at all, but merely a pill made out of sugar. Examining the actual testimony of some African participants
illustrates how what the researchers believed was informed consent was in fact not very well informed at
all. One participant, a 23-year-old woman infected with HIV, was repeatedly asked about placebos and why
they are used. The woman replied that she was given many diﬀerent pills and that she believed that “ ‘if
one of them didn’t work against AIDS, then one of the other ones would.”’47 This woman, like many others
in these trials, was illiterate, unemployed, and unmarried, and this trial was the only chance she had of
obtaining any sort of treatment at all.
Even the more educated participants can be misled into consenting to clinical trials. One single mother
who had her law degree explained that she was never told that there was a known AZT treatment that
prevented transmission of HIV from a pregnant woman to her unborn child. When she was asked how




15abruptly. ‘[She] would say quite simply that is an injustice.”’48 In countries where healthcare is absolutely
unaﬀordable for these patients, is consent truly consent? Is there really an option for these subjects? In a
society where women are subjugated socially, economically, politically, and sexually, “it is deeply problematic
to label their decision to volunteer a freely made choice.”49 Sometimes the governments of these third-world
countries allow experiments to take place on their citizens that would violate standards in the modernized
world, and thus citizens are put at risk as the result of foreign researchers taking advantage of lower standards
of ethical treatment. One example of this took place in Haiti, where a study took place of couples in which
one partner was HIV-positive and the other was not.50 While in the United States there is an available drug
(Zidovudine) that can help stop the spread of the virus from one partner to another, this treatment was being
withheld from the Haitian participants. In addition, the Haitian doctor in charge of the trials (a professor
at Cornell), told the HIV-positive participants to provide three “healthy” subjects to serve as the control
group.51 This type of behavior would never be permitted in the United States, but this study survived in
Haiti nonetheless. This oversight can be attributed in large part to the limited resources of the Oﬃce for
Protection from Research Risks (OPRR) in the Department of Health and Human Services. With thousands
of projects to review, the truth is that the ones performed domestically receive greater attention.52
It is the most vulnerable populations, therefore, who receive the least amount of protection from ethical
guidelines and restrictions. In the Nazi camps the people used against their will as subjects in research were
deemed by Hitler’s government to be of less value than Aryan citizens. Their bodies were thought to be
disposable, merely tools for the Germans to use to advance their own agenda. By making the Jews, Gypsies,
homosexuals, and countless other “undesirables” into “the other,” the Nazis could justify their behavior to
48Id. at 99
49Id. at 100
50Daniels, John. “U.S. Funded AIDS Research in Haiti: Does Geography Dictate How Closely The United States Government
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16themselves. The thought of white doctors from rich countries entering poor Black countries to do medical
experiments raises similar issues about subject as “the other” and invites further exploration into the ﬁne
ethical lines that can be crossed even with the best intentions. Despite the fact that these scientists want to
help these people ﬁght AIDS, not kill them like the Nazis did, the relative power positions of the subjects and
the researchers means that the Nuremberg Code should be even more closely followed, not side-stepped in
the name of convenience. Why are poor Black people being subjected to trials that American citizens would
not tolerate? Americans must ask themselves if the fact that some help is better than none justiﬁes using
ethical standards on other populations that are substantially lower than those we expect in our country.
Beyond the diﬀerences in levels of regulation, another disparity that must be addressed is the possibility
that those who are being subjected to these trials may not be the people who end up beneﬁting from the
results. Given the economic distress in these countries, it is likely that, even if a vaccine or extremely
eﬀective drug treatment were discovered as a result of these trials, the countries in which the experiments
took place would not be able to aﬀord such therapies as soon as they became available.53 The scientists
and physicians involved in these studies are committed to using scientiﬁc progress and innovation to ﬁnd the
cure for AIDS, or perhaps just a vaccine. As discussed previously with regard to the case law on this matter,
the American attitude embraces this focus on progress and technological advancement. American society
encourages creativity and innovation, and thus the inherent and societal values of many of the researchers
often blind the counter-weight of ethics and human rights. What emerges can be viewed as a benevolent
paternalism, wherein the wealthy white countries are telling the poorer Black ones what is good for them in
the long run. This is a diﬃcult subject to ponder because the intentions of the researchers are good; but is
that good enough to justify the kinds of experiments that have taken place? Many argue it is not.
Critics of these trials advocate for stricter adherence to the Nuremberg Code. But some people argue that
53Specter, Michael. “The Vaccine.” The New Yorker. February 3, 2003 p. 57
17data obtained through unethical means should not be used at all. This is an argument mostly used in
the context of the Nazi experiments, where the atrocities were so devastating that use of the information
gathered seems to some to deﬁle the memories of the lives lost. Some advocates of non-use do so on the
principle that the scientiﬁc practices used by the Nazi doctors were simply faulty. This argument claims
that “ﬁrst, drawn as they were from the death camps, experimentees were usually malnourished, emaciated,
and severely weakened, and thus their physiological responses to the experiments would likely be diﬀerent
from those of normal, healthy people. Second, Nazi doctors had political aspirations and sought results that
supported Nazi racial theories. Third, the data were never replicated and, in an ethical world, can never
be replicated.”54 However, some experiments, like the hypothermia experiment, produced data that could
potentially save lives and has been cited in medical literature.55 This conundrum presents a diﬃcult choice
between disqualifying the data because of its faulty methods, or using the beneﬁcial data that was obtained
to help save future lives. But beyond this initial conundrum, an even more diﬃcult issue arises: Is it moral
to use the results of these experiments?
The moral issue of non-use as a memorial touches the deepest depths of ethical beliefs and human rights,
and challenges people to see how far these doctrines should go. Museums, statues, and the preservation
of concentration camp barracks have memorialized the Holocaust. Some advocates of non-use argue that
sacriﬁcing scientiﬁc data as a memorial is no diﬀerent than sacriﬁcing the potentially valuable real estate on
which the preserved barracks stand.56 Mostow argues that because non-use interrupts the normal ﬂow of
scientiﬁc research, it “can lift scientists out of their esoteric world and reconnect them with lifeworld symbols.
Non-use can thus interject lifeworld values into the scientiﬁc enterprise. Speciﬁcally, it can convey the message
that science must not become detached from human values.”57 The idea of non-use as memorialization is
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18countered by the notion that perhaps use of this data, if helpful, can be a way to make sure these victims
did not die in vain. The debate between these two viewpoints can never be resolved, sadly, because the
world will never know what the victims would have wanted.58 This dilemma intersects with the discussion of
the ADIS trials when Mostow admits that perhaps if some of the data that was obtained had the potential,
through its use, to save millions of lives, then perhaps the beneﬁts would out weigh the costs.59 The diﬃcult
questions remains, however, because no one can say for certain whether or not these trials in third world
countries will lead to the cure for AIDS. If they do, it is likely that the retrospective view would be that these
experiments, even though perhaps not adhering strictly to the doctrine of informed consent, were worth it
because an AIDS vaccine or cure exists and millions of lives would be saved. If, however, the trials are utter
failures, many critics may argue that people were exploited and their dignity and autonomy violated simply
because of researchers’ obsession with conquering this viral enemy.
Non-use is an extreme form of memorialization and carries with it potentially far-reaching consequences.
Upon considering the remembrance of these victims, Jay Katz, a leading scholar in the ﬁeld of bio-medical
ethics, is reminded of the passage in Deuteronomy, “Tzedek, tzedek, tirdof” (Justice, justice, shalt thou
pursue). There has been much discussion of the meaning of saying justice twice, and Katz gives an example
of one explanation, which stresses that justice cannot simply be a goal or an idea, but rather is reﬂected in
the means employed to attain the goal.60 By focusing on the means instead of simply the end goal of justice,
one can see how perhaps non-use is an appropriate response. However, when faced with the reality of the
AIDS virus, Mostow’s own exception about cost/beneﬁt analysis seems more appropriate. If the trials in
Africa and Haiti lead to the cure, most people would be willing to accept the quality of informed consent
that is generally obtained.




19In defending their behavior, the American researchers often employ just that argument, stressing the dire
consequences of inaction and the beneﬁcial treatment many of these participants are receiving. Upon learning
of the experiments using placebos, many health and human rights advocates became incensed with the CDC
and called for such research be discontinued. In a letter to Donna Shalala, then-Secretary of the Department
of Heath and Human Services, the director of the Public Citizen’s Health Research Group, Sidney Wolfe,
demanded that Shalala “immediately order the researchers to stop any arm of their studies in which women
are denied access to antiretroviral drugs and to provide at least short-term AZT for all women now getting
a placebo or other unproven treatments.”61 Wolfe discussed the problems with the informed consent being
given and even compared the study to the infamous Tuskegee syphilis experiment. But the CDC defended
its actions by saying that “a placebo control will provide the best scientiﬁcally valid and credible comparison
to conﬁrm the eﬃcacy and safety of short course AZT under developing country conditions.”62 The CDC
emphasized that these women were getting more care than they would under their own country’s health care
system and argues that experiments should be done in the communities most at risk.63
Beyond defending these experiments, the CDC also went on the oﬀensive, turning a popular argument on
its head when they declared that critics of these experiments were culturally insensitive in demanding that
African countries employ the same standards as Western countries.64 Most critics use that argument when
accusing the United States of imposing their own values and standards, but here the CDC was being attacked
for not imposing its own standards and values, but rather for adopting the standards of the countries in
which the research was being performed. In bolstering its argument, the CDC claimed that the African
countries employed a more communal approach to ethics and that imposing an American, individual-based
61Letter to Dept. of HHS (HRG Publication #1430). See www.citizen.org/publications/print release.cfm?ID=6627
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20system would be inappropriate.65 In addition, the CDC researchers emphasized the oft-repeated truth that
these women, in the absence of these clinical trials, would be receiving absolutely no health care at all, thus
indicating that, in a sense, “beggars can’t be choosers.” This justiﬁcation is quite persuasive, but Dyckman
makes a strong counterclaim by asserting that the researchers manipulated the situation to defend their
behavior, explaining that in reality, the African communities are not choosing these standards at all; in fact,
they have no choice. Either they accept the Western system of testing, or they cannot participate.66
These two diﬀerent perspectives on cultural relativism provide one of the most interesting and thought-
provoking aspects of this debate. If advocates of third-world cultural autonomy oppose imposition of Western
values generally, why do they support the imposition of these same values in this particular area? This could
be an example of hypocrisy at work, or perhaps it does in fact ﬁt into the framework of a preservation of
these individuals’ autonomy. Whatever one’s position is on that issue, it seems clear that the CDC sees the
AIDS pandemic as an emergency, which must be addressed immediately and vigorously, and they are content
with the level of ethical compliance in the clinical trials. On the other side of this debate, many human
rights activists believe these trials are an example of Western exploitation of foreign bodies, motivated by
an obsession with technological advancement and achievement. These activists argue that all aspects of the
Nuremberg Code and Helsinki Document should be adhered to in all countries around the world, and that




21In weighing both sides of this intensely emotional and diﬃcult debate, it is easy to see why no clear answer
has emerged. No one would argue that the Nuremberg Code should not be followed, but rather the question
arises as to how strictly the Code must be adhered to in all situations, including emergencies. The legacy of
the Nuremberg Trials and the Code itself is a reminder of the horrors of the Nazi regime during World War
II. Many believe that if the Code is not vigorously upheld, society risks history repeating itself.67 While
most people would like to believe that the horrors of World War II could never be repeated, history has
shown man’s capacity to do harm unto his fellow man in all societies around the world. It is easy to see
what proper behavior is in extreme situations, like torture or forced experimentation. The diﬃculty arises
in situations like the clinical AIDS trials in Africa and other third-world countries. In these environments
the ethical questions are shrouded by the blurry eﬀects of a researcher’s best intentions and a participant’s
desperate need for care. Factors such as poverty, illiteracy, and cultural diﬀerences only complicate matters
further.
The ultimate question that emerges is: What price is society willing to pay for a cure for AIDS? Will the
world be happy if, upon looking back on the process, we realize that human lives were exploited and autonomy
violated? These questions remain unanswerable because the process is still in motion. The beneﬁcial eﬀect
of this ethical debate, however, is to constantly remind researchers of their ethical obligations and bring
visibility to their actions so that the world can know the truth about these trials. This openness is what
will ensure that international ethical standards will remain the guiding force behind these experiments. For
this reason alone, this constant debate between physicians, human rights activists, government oﬃcials, and
researchers is immensely important and should continue in the public arena. The Nuremberg Code, and
subsequent documents regarding the ethics of human experimentation, are crucial reminders of how low
humanity can sink in its chase for scientiﬁc advancement, and how society can ensure that such depths are
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22never reached. These documents must be respected and upheld, but at the same time, must be able to
adapt to particular circumstances and environments. It is only through this ﬂexibility and debate that true
progress, progress which society can be proud of, will be achieved.
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